Cardium Therapeutics (CXM) Reports In-Line Q1 Loss of 2c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| Cardium Therapeutics, Inc. (NYSE: CXM) | Delayed: 6.88 +0.07 (1.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.81 | 52 Week High | $1.44 | |||
| Open | $6.80 | 52 Week Low | $0.06 | |||
| Day High | $7.03 | P/E | N/A | |||
| Day Low | $6.79 | EPS | $-1.24 | |||
| Volume | 2,175,361 | |||||
